Altogether, the study suggested that inhibition of BTK in dendritic cells enhanced maturation and activation of dendritic cells and accelerated CD4+ T cell growth, which contributes to reshaping the tumor microenvironment during cancer development. This evidence concerns the gene CD4 and cancer.